Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
114.00    2.50 (2.24%)
Bid:
112.00
Ask:
116.00
Spread: 4.00 (3.571%)
Market Cap: £68.59m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

MyID within Intel Authenticate

1 Mar 2016 14:00

RNS Number : 6444Q
Intercede Group PLC
01 March 2016
 

 

 

PRESS RELEASE

 

Intercede Eliminates Passwords in the Workplace

 

New software from Intercede provides added protection using Intel® Authenticate for enterprise PCs

 

RSA CONFERENCE 2016, San Francisco, March 1, 2016 - Today, digital identity and credentials expert Intercede announced new security software designed for deployment alongside Intel's latest hardware-based identity protection technology, Intel® Authenticate. Intercede software, running on the 6th Gen Intel® Core™ vPro™ processor, works in combination with Intercede's MyID credentials management solution to replace password-based access control for networks, applications and services with certificate-based, highly secure and convenient hardware-backed protection.

 

Intel and Intercede have worked together to integrate Intercede's Minidriver and Virtual Reader software - a development of the company's core MyID platform - within Intel Authenticate. Available in preview, Intel Authenticate is a hardware-enhanced, multifactor authentication solution that strengthens identity protection on the PC, making it less vulnerable to identity breaches and security credential attacks. Intercede will complement Intel Authenticate by making hardware-backed credentials available for Windows and domain logon, as well as making credentials issuance and management simpler and more scalable.

 

Enterprise customers will now have the ability to utilize Intercede's MyID solution to easily issue and manage the credentials lifecycle. MyID was the first electronic personalization system to achieve FIPS 201 compliance in the U.S. and a leading and established choice for national governments and major companies in the aerospace and defense sector entrusted with protecting some of the world's most sensitive data. Enterprises will soon be able to use Intercede's high security technology with Intel Authenticate to remove the need for usernames and passwords and provide higher levels of user authentication.

 

"Intel Authenticate is a solid technology built to intelligently help secure Windows based platforms in today's enterprise environments," said Richard Parris CEO of Intercede. We are proud to be working with Intel to provide differentiating technology that works with their new generation solution. Intel Authenticate, coupled with MyID, enables end-user companies to focus on their business and to protect their workforce and assets with a more highly secure solution that is cost-effective, easy to deploy and manage across a global enterprise."

 

"We're excited to advance our work on Intel Authenticate, working with premier security companies like Intercede. Together, we're empowering enterprise to not only dramatically improve identity security, but to do so in a way that improves the ease of use and experience for the business professional," said Tom Garrison, vice president and general manager for the Intel Business Client Division.

 

To preview the new security technology first hand, demonstrations will be available during the RSA 16 conference in San Francisco. For more information at the show, stop by the Intel RSA 16 booth located at North Expo D3705.

 

 

Enquiries:

 

Intercede Group plc Tel: 01455 558111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

 

finnCap Ltd Tel: 020 7220 0500

Stuart Andrews, Corporate Finance

Joanna Scott, Corporate Broking

 

 

Notes to editors

 

MyID

For a credential to be trusted it needs to be managed, an organization needs to know that the right people have been issued the correct credentials, this is what MyID provides. The existing MyID platform has been enhanced to support issuance and management of Intel Authenticate® chip-protected credentials, allowing an organization to deploy and use them simply and at scale.

 

 

About Intercede

Intercede is a software and service company specializing in identity, credential management and secure mobility. Its solutions create a foundation of trust between connected people, devices and apps and combine expertise with innovation to provide world-class cybersecurity. Intercede has been delivering solutions to high profile customers, from the US and UK governments to some of the world's largest corporations, telecommunications providers and information technology firms, for over 20 years. Intercede's product portfolio includes MyID, an identity and credential management system that assigns trusted digital identities to employees citizens and machines. In 2015, Intercede launched MyTAM, enabling trusted applications to be loaded into a mobile device's Trusted Execution Environment (TEE), providing hardware-level security for Android apps.

 

For more information visit: www.intercede.com or follow us on Twitter: @IntercedeMyID

 

Intel and Intel Authenticate, Intel Core vPro are registered trademarks of Intel Corporation in the United States and other countries.

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAADFEFNKEFF
Date   Source Headline
25th Nov 20247:00 amRNSTransaction in Own Shares
22nd Nov 20247:00 amRNSTransaction in Own Shares
19th Nov 20247:00 amRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares
15th Nov 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSTransaction in Own Shares
8th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSNotice of Results & Investor Presentation
25th Oct 20247:00 amRNSShare Buyback Programme
11th Oct 20248:38 amRNSDirector/PDMR Shareholding
8th Oct 20247:00 amRNSTrading Update
1st Oct 20247:00 amRNSNotification of Trading Update and H1 FY25 Results
30th Sep 20247:00 amRNSContract Orders and Renewals
25th Sep 202412:51 pmRNSResult of AGM
20th Sep 202411:45 amRNSDirector/PDMR Shareholding
18th Sep 20247:00 amRNSContract Orders and Renewals
2nd Sep 20247:00 amRNSContract Orders and Subscription Renewals
30th Aug 20247:00 amRNSNotice of AGM and Publication of Annual Report
4th Jul 20243:58 pmRNSIssue of Equity & Total Voting Rights
28th Jun 20243:49 pmRNSIssue of Equity & Total Voting Rights
26th Jun 20247:00 amRNSPartnership with Carahsoft Technology Corp
19th Jun 20246:25 pmRNSHolding(s) in Company
18th Jun 20249:17 amRNSHolding(s) in Company
18th Jun 20247:15 amRNSDirector/PDMR Shareholding and Issue of Equity
18th Jun 20247:00 amRNSFinal Results
5th Jun 20247:00 amRNSNotice of Results & Investor Presentation
16th May 202412:00 pmRNSCapital Markets Day - Agenda Update
14th May 20246:17 pmRNSShare Incentive Scheme
26th Apr 202410:02 amRNSShare Incentive Scheme
23rd Apr 20247:00 amRNSCapital Markets Day
8th Apr 20247:00 amRNSTrading Update
2nd Apr 20247:00 amRNSContract and Subscription Renewals
25th Mar 20243:38 pmRNSHolding(s) in Company
25th Mar 20243:35 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSNew Orders and Trading Update
21st Mar 20247:00 amRNSNew Product Announcement: Launch of MyID MFA v5
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSNew Orders
18th Jan 20249:55 amRNSDirector/PDMR Shareholding
3rd Jan 20247:00 amRNSMajor New Contract Win
7th Dec 20237:00 amRNSUpdate on Major New Contract Win
5th Dec 202312:30 pmRNSMajor New Contract with Large US Federal Agency
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:01 amRNSNew Contract and Renewal Orders
21st Nov 20237:00 amRNSHalf-year Report
7th Nov 20237:00 amRNSContract and Renewals Orders
25th Oct 20234:44 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.